• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Harrison Street Acquires Osborn Triangle, a State-of-the-Art Office and Laboratory Complex Located in Cambridge, Mass.

Share:

May 28, 2019

Harrison Street, one of the largest alternative real asset investment firms dedicated to the Education, Healthcare and Storage sectors, today announced it has acquired Osborn Triangle from a subsidiary of the Massachusetts Institute of Technology. Osborn Triangle is a state-of-the-art, multi-tenant office and laboratory complex located in East Cambridge/Kendall Square alongside some of the world’s top educational and research institutions. Harrison Street partnered with the Bulfinch Companies, Inc., a Boston-based, private commercial real-estate investment, development and management firm, and a subsidiary of MIT, which retained a partial interest in the property. Under the arrangement, MIT will retain long-term ownership of the land.

Osborn Triangle is directly adjacent to MIT’s campus. The complex encompasses three buildings – 610 Main Street North, 1 Portland Street and 700 Main Street – with 676,917 square feet and an associated 650-space parking garage. Each building has been either recently renovated or built and the property is complemented by vibrant street-level retailers: Sulmona (Italian restaurant), Café Luna, Revela (an Aveda salon) and Boston Burger Company. The complex is fully leased to seven tenants and includes three anchor tenants: Pfizer, Inc., Novartis International AG, and LabCentral, an incubator for high-potential life-sciences and biotech startups.

Christopher Merrill, Harrison Street’s Co-Founder, Chairman and Chief Executive Officer, said, “We are thrilled to partner with MIT and the Bulfinch Companies to invest in and support one of the most cutting-edge neighborhoods serving the biotech, medical and scientific research and development communities. Harrison Street is committed to providing our tenants and communities we serve with high-quality facilities and world-class amenities and it is a privilege to be part of this vibrant Boston community for the long-term.”

Mark Burkemper, a Managing Director at Harrison Street, added, “Osborn Triangle is a one-of-a-kind complex serving as a global hub for the life science and innovation communities, supported by high barriers to entry and blue-chip tenant base. The East Cambridge/Kendall Square submarket is very attractive, with vacancy rates of less 1%, and we are excited by the opportunities to continue to enhance this already thriving neighborhood.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Date: May 28, 2019

Source: Business Wire

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Samsung Upcycles Older Phones to Diagnose Eye Diseases in Impoverished CommunitiesSamsung Upcycles Older Phones to Diagnose Eye Diseases in Impoverished Communities
  • Health and Social Care Northern Ireland Taps Tegria for National Digital TransformationHealth and Social Care Northern Ireland Taps Tegria for National Digital Transformation
  • Cynosure Acquires Palomar Medical TechnologiesCynosure Acquires Palomar Medical Technologies
  • Taiwanese Mobile Health Firm Ixensor Introduces Telehealth Service Assisting At-Home Fertility MonitoringTaiwanese Mobile Health Firm Ixensor Introduces Telehealth Service Assisting At-Home Fertility Monitoring
  • Quibim Works with Highlight Therapeutics to Improve Immunotherapy in Melanoma with AIQuibim Works with Highlight Therapeutics to Improve Immunotherapy in Melanoma with AI
  • Chronic Condition Management Startup Sweetch Scores $20MChronic Condition Management Startup Sweetch Scores $20M
  • AI can Predict which Research will Translate to Clinical TrialsAI can Predict which Research will Translate to Clinical Trials
  • Ligand Sells Promacta Assets and Royalty for $827 MillionLigand Sells Promacta Assets and Royalty for $827 Million

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications